Dineout Founders Ankit Mehrotra and Sahil Jain have secured $4.5 million in a Seed funding round, led by prominent global VC fund Nexus Venture Partners, for their latest venture, UK and India-based medical travel startup, The Medical Travel Company. Kriscore Capital, an early-stage venture firm, also joined in this funding round along with cricketers Ben Stokes, Jofra Archer, and KL Rahul, all co-founders of 4CAST, an athlete-led collective and investment group.
Together, they will bring their collective influence and experience of India’s healthcare system to support The Medical Travel Company in its goal: to initially target the UK and create reliable, seamless pathways for patients to access world-class treatment in India at considerably lower costs. The funding will help The Medical Travel Company, which is based out of both UK and India, drive market expansion in the UK and scale operations across India.
As of June 2025, approximately 7.7 million people in the UK face long waits for elective procedures, particularly in orthopaedics, dental, IVF, gynaecology, ophthalmology and urology. With private care in the UK often unaffordable, medical tourism has surged — over 500,000 UK residents now travel abroad annually for faster, more affordable treatment.
However, the $100bn industry has historically struggled with fragmented services, opaque pricing, inconsistent quality standards, and poor aftercare, leaving patients and primary caregivers uncertain, stressed, and sometimes at risk.
The Medical Travel Company was founded by Sahil Jain and Ankit Mehrotra, the duo behind one of India’s most successful consumer-tech stories – Dineout, the restaurant-tech platform that redefined dining in India before its 2022 acquisition by Swiggy.
The serial entrepreneurs are solving for the critical gaps in medical travel by providing:
- Trusted UK Medical Oversight: Your own UK doctor remains involved before, during, and after treatment.
- World-Class Clinical Excellence: Treatment from internationally-trained doctors in globally accredited (JCI, NABH) hospitals.
- Unprecedented Peace of Mind: An industry-first, 12-month post-surgery insurance policy valid back in the UK at a network of private hospitals
- Seamless VIP Experience: A fully managed journey with in-house, personalised, all-inclusive after care and concierge logistics.
Sahil Jain, Co-Founder & CEO of The Medical Travel Company, comments: “Medical tourism is a broken industry: patients face fragmented care, hidden costs, and zero support when they return home. The Medical Travel Company ensures true continuity of care across borders: UK doctors overseeing your care from start to finish, all-inclusive rehab and aftercare in India, and post-treatment insurance in the UK. What begins in the UK is only the first chapter of a larger vision to transform cross-border healthcare access across the Western world. Because for us, it’s not medical tourism. It is healthcare certainty.”
“We’re not just disrupting medical tourism – we’re rebuilding it from the ground up. With our Dineout experience in scaling consumer trust across borders, we know how to turn a fragmented industry into a seamless experience. Today, it’s 500,000 UK patients travelling abroad for care. Tomorrow, there will be millions globally accessing the world’s best treatment regardless of geography. We’re building the infrastructure for healthcare without borders,” added Ankit Mehrotra, Co-Founder, The Medical Travel Company.
Some prominent Angel investors like Sriharsha Majety (Co-founder, Swiggy), Abhishek Goyal (Founder of Tracxn), Dr. Ritesh Malik (Innov8), Manish Vij (Smile Group), Arjun Vaidya (Dr Vaidya’s and V3 Ventures) along with 1947 Rise Fund and Peercheque also participated in this round.
The funds will be used to scale The Medical Travel Company’s operations, enhance digital patient management systems, expand clinical partnerships across India, and accelerate market expansion. While initially focussed on the UK, The Medical Travel Company plans to expand its model to other geographies facing similar challenges — including the US, Canada, Australia and the rest of Europe — over the next three to four years.
Pratik Poddar, Partner at Nexus Venture Partners, said: “The medical tourism market holds immense untapped value, and The Medical Travel Company’s full-stack model is the key to unlocking it. Having founded one of India’s most successful consumer-tech stories, Sahil, Ankit and their team are uniquely positioned to build trust and capture this opportunity. India has long been a leading medical frontier, with world-class practitioners and cutting-edge technology; it’s about time this excellence is made globally accessible.”
Nilesh Balakrishnan, Managing Partner, Kriscore Capital, said: “Ankit and Sahil have already proven their ability to build at scale, and with The Medical Travel Company they are addressing one of the most urgent healthcare gaps while showcasing India’s strengths on the global stage. Access to timely, affordable healthcare is becoming one of the defining challenges of our time, and The Medical Travel Company is setting a new standard for how this can be solved.”
Ben Stokes, founder of 4CAST and captain of the England Test team, said: “We are delighted to announce our investment in The Medical Travel Company. When we first started 4CAST in 2021 we wanted our collective of athletes to be able to partner with innovative businesses and great founders. We feel we have done so here and we are excited to back Ankit and Sahil and look forward to supporting their journey ahead with TMTC.”
K.L. Rahul, Co-founder, 4CAST, added, “It is fantastic to announce this investment between 4CAST and The Medical Travel Company; we feel it is a perfect combination. Having grown up in India, I’ve witnessed the country’s development across many industries over the years. We are hugely excited about working alongside Ankit, Sahil and their team to help create new pathways for patients while ensuring proper support throughout the entire process.”
